> No interaction studies have been performed.For the adjunctive use of VERTEPORFIN PHOTODYNAMIC THERAPY (PDT) and XIMLUCI in wet AMD and PM, see section 5. 1.For the adjunctive use of laser photocoagulation and XIMLUCI in DME and BRVO, see sections 4.2 and 
5.1.In clinical studies for the treatment of visual impairment due to DME, the outcome with regard to visual acuity or central RETINAL subfield thickne ss (CSFT) in patients treated with ranibizumab was not affected by concomitant treatment with THIAZOLIDINEDIONES.

